Medigene announces KRAS G12V as first target for TCR-guided T cell engagers: Planegg, Germany Tuesday, December 10, 2024, 17:00 Hrs [IST] Medigene AG, an oncology platform company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback